During the past decade, Kardiologická ambulance conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kardiologická ambulance" are "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiac Arrhythmias" (1 trials), "Coronary Artery Disease" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Kardiologická ambulance" in a lesser frequency.

Most popular intervention types in "Kardiologická ambulance" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Plavix (clopidogrel 75 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kardiologická ambulance" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kardiologická ambulance". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kardiologická ambulance, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kardiologická ambulance, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".